VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO WCGIC 2020 | PEMREC: neo-adjuvant pembrolizumab and RT in rectal cancer

Thibaud Kössler, MD, PhD, of Geneva University Hospital, Geneva, Switzerland, discusses the rationale and trial design of PEMREC (NCT04109755), an ongoing Phase II study evaluating safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy (RT) in localized microsatellite stable rectal cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter